- high
maintenance costs to its
manufacturer uniQure, and
failure to
achieve approval in the US, led to
uniQure withdrawing the drug
after two
years on the...
-
Retrieved 2019-11-25. "
uniQure Announces It Will Not S****
Marketing Authorization Renewal for
Glybera in Europe" (PDF).
uniQure.
Retrieved 2019-11-25....
- Commission".
UniQure (Press release). 2
November 2012.
Archived from the
original on 5
November 2012.
Retrieved 2
January 2022. "Chiesi and
uniQure delay Glybera...
- the small-cap
market space.
September 20, 2021
QURE uniQure N.V. UIHC
United Insurance Holdings Corp.
QURE replaced UIHC
which was no
longer representative...
- NIBR,
Dolmetsch was
appointed president of
research and
development at
uniQure, a
company developing gene
therapies for the
liver and the
central nervous...
- by
European Commission". BBC News.
Retrieved 2023-07-02. "
UniQure -
Press Release".
uniqure.com. 2012-11-05.
Archived from the
original on 2012-11-05...
-
balance was unfavourable. A huntingtin-lowering gene
therapy trial run by
Uniqure began in 2019, and
several trials of
orally administered huntingtin-lowering...
-
published papers focusing on Gene
therapy (ASC, AveXis, UCLA Ventures,
UniQure, and Symvivo), immuno-oncology (Amgen, AstraZeneca, Belli****, and Jazz)...
- work on the project,
Secure information processing in
quantum networks (se
QureNet).
During the
project she
created integrated photon sources,
fibre components...
